General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises Underwriters in Phreesia’s Public Offering of Common Stock

April 13, 2021
Multidisciplinary team represented the underwriters in the offering by the patient intake management platform.

Phreesia, Inc., a leading patient intake management platform, has announced the closing of the underwritten public offering of 5,175,000 shares of its common stock all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of US$50 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount. The Company received net proceeds from the offering of approximately US$245.3 million after deducting underwriting discounts and estimated offering expenses.

Latham & Watkins LLP represented the underwriters in the offering with a capital markets team led by New York partner Stelios Saffos, with associates Brittany Ruiz, Brian Yoon, and Egzon Sulejmani. Advice was also provided on tax matters by New York partner Jiyeon Lee-Lim, with associate Ron Moore; on payments matters by Washington, D.C. partner Todd Beauchamp, with associate Loyal Horsley; and on data privacy and cybersecurity matters by Washington, D.C. partner Jennifer Archie, with counsel Marissa Boynton.